Lecture Series - Regulatory Science and Translational Research - Part 5
- –
- Zoom Video Lecture
Dr. Christian Schneider,
VP & Chief Medical Officer, Clinical Development Services
PharmaLex Cencora
Part 5: “Interaction with regulators, e.g. in preparation of a first clinical study”
• What are the possibilities?
• How does one plan this interaction optimally? What to do as an academic group?
• Which special possibilities does one have when developing „Advanced Therapies“ (gene therapies, cell therapies, tissue engineering products)?
• From practice: How does a Scientific Advice meeting with regulators look like? What happens there? How to prepare?
Video lecture via Zoom: https://us02web.zoom.us/j/87291312496?pwd=nR5z2p5mstOCa7LRvwW5MDmbtuiY6W.1
(The lectures will be held in English)
Upcoming lectures:
05.05.2026: Part 6 "Challenge Orphan medicines – learnings from the past"
13.10.2026: Part 1 "Why is knowledge in regulatory science important for translational medicine and basic science?"